Asston Pharmaceuticals Ltd. IPO Details

Initial Public Offerings (IPOs) allow you to invest in companies going public. Asston Pharmaceuticals Ltd. goes public when it first sells its shares after being listed on BSE or NSE.

Asston Pharmaceuticals Ltd.

Objective

1. Funding capital expenditure requirements towards acquiring machinery in the manufacturing unit;
2. Funding the incremental working capital requirements of our Company;
3. Repayment and/or prepayment, in part or full, of certain of our outstanding borrowings availed by ourCompany; and
4. General Corporate Purposes

IPO Details

Face Value ₹ 10.00 Per Share

Issue Size ₹ 0.00 - 0.00 Cr

Price Band ₹ 0.00 - ₹ 0.00 Per Share

Issue Type Book building

Business Description

Our Company is engaged in the manufacturing and export of both pharmaceutical formulations and nutraceutical products indomestic and various

...

African markets. Our Company operates under brand “Asston”. Presently, our Company is involved in thebusiness of manufacturing and marketing of Tablets, Capsules, Oral Liquid, External Preparations (Ointment, Cream, Gel andLotion) and Oral Powder (Sachet, Dry Syrup) etc. Apart from manufacturing products for direct sales, our Company alsomanufactures various pharmaceutical products for different marketers on loan license or on contract manufacturing basis. Ourbusiness is primarily conducted on a principle-to-principle basis with various marketers.As on the date, we cater to multiple corporate clients on loan licence and/or contract manufacturing basis. Currently, our Companyhas its production facility at Ambernath, Maharashtra, for producing generic medicines in the tablet form and nutraceuticalmedicines in the tablet form, syrup and sachet form. We have a dedicated and separate floors for pharmaceutical products andnutraceutical products respectively as the norms and standards are different for both of them and are governed by FDA and FSSAIrespectively. Since the FDA norms for pharmaceutical products are much more stringent, to comply with FDA standards separateguidelines are there to be followed. Facility has total production capacity of up to around 8-9 crore tablets per month. Our Companyproduces an average of 5-6 crore tablets per month, with production capacity varying based on the weight of the medicines. Higherweightmedicines result in lower production quantities and vice versa. The syrup production capacity for nutraceuticals isapproximately 37.5 kiloliters per month, while sachet production capacity ranges from 30 to 40 lakh sachets per month, dependingon the powder weight per sachet. The facility is certified by relevant authorities and undergoes periodic audits by state and centralFDA authorities. It includes a QA/QC unit and a warehouse for storing raw materials and finished goods in designated chambersunder controlled conditions. Our Company engages contract manufacturers to produce generic medicines and antibiotics in variousforms, including tablets, sachets, syrups, and capsules. All contract manufacturers are WHO-GMP certified to ensure their facilitiesand processes comply with applicable standards and industry norms. Read More

About IPO

Listed At BSE

Promoters

Ashish Narayan Sakalkar

Saili Jayaram More

Sachin Chandrakant Badakh

Promoter's Holding

Open Demat Account today!

Full Name

Enter Full Name

Mobile Number

Enter mobile number

Select Partner

Frequently asked questions

What is an IPO?

An Initial Public Offering (IPO) is when a private company sells shares to the public for the first time, enabling investors to purchase these shares and gain partial ownership in the business. For instance, if a well-known tech firm wants to grow and requires additional funds, it might choose to go public through an IPO. During this process, investors can buy shares, and the company’s stock starts trading on the stock exchange on the day of the IPO listing.

How can I apply for an IPO?

Investors can apply for an IPO through their bank or brokerage account. Many trading platforms have a specific section for IPOs where users can submit their applications online.

What is the difference between the primary and secondary market in relation to IPOs?

The primary market is where shares are offered to the public for the first time via an IPO. After the IPO, shares are traded on the secondary market (stock exchange), where existing shareholders can sell to new buyers.

What are the benefits of investing in an IPO?

Investing in an IPO offers the opportunity to become an early investor in companies with high growth potential, at a price which may be lower than their post-listing market value. It provides a chance to participate in the company's growth journey from its early stages. However, IPO investments also come with inherent risks, such as market volatility and uncertainties about the company's future performance.

What are the key factors determining the IPO price?

The price of an IPO is established through a systematic process known as "book building." In this method, investors bid within a given price range, and the final price is set based on demand and market conditions. Several factors play a crucial role in determining the IPO price, including:

Past Financial Performance: Evaluating the company's revenue, profits, and financial stability over time
Growth Potential: Assessing future prospects based on the company's business model and market opportunities
Industry Peers: Comparing valuation metrics with similar companies in the same sector
Larger Industry Picture: Analysing overall industry trends and economic conditions that could impact the company's performance

Disclaimer

This content is for educational purpose only and the same should not be construed as investment advice. Bajaj Finserv Direct Limited shall not be liable or responsible for any investment decision that you may take based on this content.

Open a Demat Account today!

Full Name Enter Full Name

Mobile Number Enter Valid Mobile Number

Select partner from dropdown

Disclaimer

All content and research information displayed on the Site, are obtained from our partner Accord Fintech Private Limited. an authorized data feed vendor of BSE/NSE/MCX/NCDEX exchange. The data is provided on ‘As-Is’ basis and is not a live data feed but a feed with 15 minutes delay or more. Bajaj Markets does not warrant accuracy, completeness, timely availability of the information and data available on the Site. Past performance, when presented, is purely for reference purposes and is not a guarantee of similar future results.

The Services offered on the Site does not constitute investment advice in any manner whatsoever. You shall be solely responsible for any investment decisions made by placing reliance on the information provided on the Site.

Bajaj Markets partners with financial services entities for sourcing leads for services such as DEMAT accounts etc. In case you wish to avail the services, you shall be redirected to partners platform and shall be bound by the terms and conditions, privacy policy governing the said platform.